‘Medicare for All’: What would it really mean for healthcare stakeholders?
“Medicare for All” would have varying impacts on hospitals, physicians and health plans but would be expected to cause financial hardship in the majority of cases.
Why initiate health plan contract testing?
Various circumstances require providers to prepare for the impact of payment changes.
How to use contract testing and analysis to prepare for payment change
Whether a contract is new or up for renewal, a thorough understanding of the financial implications of changes to provider-payment terms is vital for continued operations.
Analysis: Timeline for CMS’s mandatory radiation oncology model appears to slip
It’s not surprising CMMI has slowed its pace on finalizing the proposed mandatory radiation oncology payment model given the complexity of the model and stakeholder opposition.
Analysis: More options for providers looking to directly contract with employers for episodes of care
Platforms like Carrum Health’s are meeting the demands of employers for higher-value care and the providers who want to meet these demands.
Analysis: What healthcare providers need to know about short-term limited-duration health insurance products going into 2020
Healthcare providers need to be aware they will likely encounter an increase in the number of patients who have purchased short-term health insurance, with its limited benefits, that will be available on the healthcare exchange in 2020.
Take this job and shove it: 2 PTAC members quit in frustration over CMMI opposition to committee recommendations
The result of CMMI’s reluctance to accept recommendations from the field is one of many factors that stymies the transition to value.
Analysis: ‘Medicare for All’ supporters more concerned about cost
New survey results: Those that favor Medicare for All are more dissatisfied with the cost of healthcare and concerned about paying for care if they became ill.
How to make annual price reviews as easy as paying your bills
Sponsored content: Healthcare organizations seeking to stay on top of new price transparency regulations should use a strategic pricing model to ensure their prices are in line with those of their market.
Analysis: 2018 Medicare ACO results: Promising but not sufficient
A review of CMS’s recently released 2018 MSSP prompts HFMA’s Chad Mulvany to suggest as a society, the U.S. needs find additional ways to close the deficit between our means to pay for federal healthcare programs and what these programs cost.